LSM11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.882600E-01
Normal-vs-Stage2
8.039200E-01
Normal-vs-Stage3
1.329200E-01
Normal-vs-Stage4
5.461200E-01
Stage1-vs-Stage2
8.769200E-01
Stage1-vs-Stage3
7.556200E-02
Stage1-vs-Stage4
1.947390E-01
Stage2-vs-Stage3
1.978970E-01
Stage2-vs-Stage4
2.295800E-01
Stage3-vs-Stage4
7.618300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.728800E-01
Normal-vs-AfricanAmerican
4.676800E-01
Normal-vs-Asian
4.478200E-01
Caucasian-vs-AfricanAmerican
5.633600E-01
Caucasian-vs-Asian
3.407600E-01
AfricanAmerican-vs-Asian
8.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.723000E-01
Normal-vs-Female
7.557200E-01
Male-vs-Female
8.885400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.418600E-01
Normal-vs-Age(41-60Yrs)
8.745400E-01
Normal-vs-Age(61-80Yrs)
6.712200E-01
Normal-vs-Age(81-100Yrs)
3.508000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.431400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.704200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.948000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.354200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.784200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.235600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.205600E-01
Normal-vs-Daily Drinker
4.590600E-01
Normal-vs-Weekly Drinker
8.497600E-01
Normal-vs-Occasional Drinker
7.454200E-01
Normal-vs-Social Drinker
6.139000E-01
Non Drinker-vs-Daily Drinker
8.138600E-01
Non Drinker-vs-Weekly Drinker
2.155200E-01
Non Drinker-vs-Occasional Drinker
2.021600E-01
Non Drinker-vs-Social Drinker
5.469900E-02
Daily Drinker-vs-Weekly Drinker
3.712600E-01
Daily Drinker-vs-Occasional Drinker
3.704800E-01
Daily Drinker-vs-Social Drinker
7.350300E-02
Weekly Drinker-vs-Occasional Drinker
8.904400E-01
Weekly Drinker-vs-Social Drinker
2.225400E-01
Occasional Drinker-vs-Social Drinker
1.711570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.810210E-01
Normal-vs-Grade 2
8.226500E-02
Normal-vs-Grade 3
6.280100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.221600E-01
Grade 1-vs-Grade 3
2.763800E-01
Grade 1-vs-Grade 4
1.810210E-01
Grade 2-vs-Grade 3
8.143200E-01
Grade 2-vs-Grade 4
8.226500E-02
Grade 3-vs-Grade 4
6.280100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.045600E-01
Normal-vs-NonDiabetic
6.219400E-01
Diabetic-vs-NonDiabetic
5.209400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.227200E-01
Normal-vs-NoPancreatitis
6.163600E-01
Pancreatitis-vs-NoPancreatitis
2.502800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.283800E-01
Normal-vs-N1
8.226200E-01
N0-vs-N1
3.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.722000E-01
Normal-vs-TP53-NonMutant
6.170200E-01
TP53-Mutant-vs-TP53-NonMutant
7.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
